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http:WHAT THIS PAPER ADDS
The basic element in the treatment of chronic venous insufﬁciency is compression therapy, which has been
suggested to be as effective in relieving symptoms as surgical treatment of venous reﬂux. The main purpose of
surgery is to eliminate venous reﬂux and to correct the pathological venous haemodynamics. In non-
complicated venous reﬂux, the indications for surgery are more or less relative and not unambiguous. In the
current study we compared compression therapy and surgery of superﬁcial venous reﬂux in a randomized
controlled trial. The main result was that patients who underwent surgery showed signiﬁcant improvement in
the measures of clinical severity of the disease as well as in disease-speciﬁc quality of life compared with those
patients who were under compression therapy only. In addition, after the study follow-up ended, almost all
patients in the compression therapy group sought treatment for the superﬁcial venous reﬂux.Objective: Superﬁcial venous reﬂux and varicose veins are common. The aim of this randomized controlled trial
was to assess effectiveness of compression therapy compared with surgery for superﬁcial venous reﬂux.
Methods: 153 patients with CEAP class C2eC3 and superﬁcial venous reﬂux were randomized to receive either
conservative treatment (compression stockings) (n ¼ 77) or surgery (n ¼ 76). Clinical examination including
duplex ultrasound (DUS) was performed at entry and 1 and 2 years after randomization (compression group) or
surgery (surgery group). Venous Clinical Severity Score without compression stockings (VCSS-S), Venous
Segmental Disease Score (VSDS), Venous Disability Score (VDS), and health-related quality of life (HRQoL) were
assessed at entry and at the follow-ups. Data were analysed on an intention-to-treat basis and according to the
actual treatment performed.
Results: At 2 years, 70/76 patients in the surgery group and 11/77 patients in the compression group had been
operated on. VCSS-S decreased from 4.6 to 3.5 in the compression group (p < .01) and from 4.8 to 0.6 in the
surgery group (p < .001). VSDS decreased from 7.7 to 7.0 in the compression group and from 8.2 to 0.9 in the
surgery group (p < .0001). HRQoL did not change in the compression group, but improved signiﬁcantly in the
surgery group.
Conclusion: The surgical elimination of non-complicated superﬁcial venous reﬂux is an effective treatment when
compared with providing compression stockings only.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The prevalence of superﬁcial venous reﬂux in saphenous
veins or their tributaries is 30e40% among the adult pop-
ulation in Western countries, and milder local venous pa-
thology can be seen in up to 80%.1e6 The clinical symptoms
and signs of superﬁcial venous reﬂux vary from aresponding author. M. Venermo, Helsinki University Central Hospi-
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//dx.doi.org/10.1016/j.ejvs.2014.02.015completely asymptomatic situation to severe venous hy-
pertension with an ulcer. The clinical degree of severity is
not easy to evaluate because the symptoms are subjective
unless the patient has visible cutaneous changes or an ulcer.
The gold standard and the most reliable diagnostic method
for detecting venous reﬂux is DUS,7e9 which should be
performed on every patient with the patient in upright
position.
The basic element in the treatment of symptoms caused
of chronic venous disease is compression therapy,10 which
reduces venous hypertension, reﬂux, and oedema, as well
as improves the effectiveness of the calf muscle pump.11
The most widely used form of compression therapy is
compression stockings, which provide distally increasing
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has been suggested to be as effective in relieving symptoms
as surgical treatment of venous reﬂux.12
The main purpose of superﬁcial venous surgery is to
eliminate venous reﬂux and to correct the pathological
venous haemodynamics. Indications for venous surgery
have included a variety of symptoms and signs such as
cosmetic reasons, aching pain, leg heaviness, leg fatigue,
superﬁcial thrombophlebitis, bleeding, and skin changes
related to chronic venous insufﬁciency. In non-complicated
superﬁcial venous reﬂux, the indications for surgery are
more or less relative and not unambiguous. Prerequisites
for surgery are always evaluated individually, with assess-
ment of potential risks related to surgery as well as to the
attainable beneﬁts.
In 2004, the Finnish Ministry of Health and Social Affairs
invited a panel of experts to deﬁne which patients should
have surgery compensated by public funding instead of
using mere compression therapy.13 As a result of this
report, a scoring system (Table 1) was implemented with
the recommendation that a patient should score 50 points
in order to receive publicly funded superﬁcial venous
surgery.
As this scoring system was heavily criticised, we set up a
study to assess whether this recommendation was truly
based on evidence. The aim of the present study was to
compare compression therapy and surgery of varicose veins
in a randomized controlled trial (RCT).
METHODS
Participants
The inclusion criteria for patients were: (1) signiﬁcant su-
perﬁcial truncal venous reﬂux veriﬁed with DUS; (2) clinical
class (CEAP) C2eC3 disease;14 (3) a venous disability score
of IeIII (I ¼ symptomatic but able to carry out usual ac-
tivities without compression therapy, II ¼ able to carry out
usual activities or an 8-hour working day only with
compression and/or limb elevation, III ¼ unable to carry out
usual activities even with compression and/or limb eleva-
tion);15 (4) patient is willing to participate in the study and
to sign an informed consent; and (5) age 20e70 years.
A total of 500 consecutive patients at the Helsinki Uni-
versity Central Hospital outpatient clinic for venous diseases
were examined between September 2004 and May 2006.
One hundred and ﬁfty-three patients fulﬁlled the study
criteria and were randomized to receive surgery or con-
servative treatment with compression stockings. A total of
347 patients were excluded, the most common reason be-
ing the severity of the disease, that is clinical class C4eC6
(Table 2).
All patients received class II compression stockings
(Venosan) free of charge immediately, and those in the
compression group received two pair of compression
stockings free of charge. In all patients, the dimensions of
the leg were measured and the stockings were selected
individually based on the circumference of ankle and calf as
well as length of the extremity from the ﬁbular head to themalleolar level. Patients were taught how to put on and off
the stockings and they received a written information how
to use the stockings. The advice was to wear the stocking all
day long during the time they were in upright position.
Surgery was performed based on the DUS examination.
All patients were treated under general anaesthesia. Great
saphenous vein and the side branches were ligated from
the groin and retrograde pin stripping performed. In the
case of SSV insufﬁciency, the vein was revealed from
popliteal fossa and ligated at the saphenopopliteal junction.
Thereafter, retrograde stripping was performed. If there was
isolated insufﬁciency of the anterior or posterior accessory
saphenous vein (AASV or PASV), the vein was ligated from
the groin and removed. Major insufﬁcient perforators were
revealed, ligated, and cut. All patients underwent local
phlebectomies. In 123 (80%) patients, GSV (n ¼ 96), SSV
(n ¼ 22), or both (n ¼ 5) were removed. In 19 (6.5%) cases
the anterior or posterior ASV was ligated and removed. Ten
(6.5%) patients underwent ligation of an insufﬁcient
perforator vein and in one case only local phlebectomies
were done.
Randomization
The randomization was performed at the outpatient clinic
by selecting and opening an opaque, sealed envelope after
the patient had been assessed as eligible for the trial, the
study had been explained to the patient, and the patient
had expressed consent to participate. Sequentially
numbered envelopes were prepared by a statistician with
no clinical involvement. Randomization was done in blocks
of six patients.
Baseline and outcome assessments
At the beginning of the study, all patients underwent a
clinical examination including DUS. All patients were
examined by the same vascular surgeon (HS). The baseline
DUS ﬁndings are described in Table 3. To measure HRQoL,
the Aberdeen questionnaire was used as it speciﬁcally as-
sesses HRQoL in patients with varicose veins.16 Because the
main treatment of one of the two groups was compression
therapy, the information of compression treatment was left
out from the ﬁnal scores.
Clinical examinations including DUS were performed at
entry, at 1 and 2 years after randomization. The 1- and 2-
year follow-up examinations were performed by the initial
examiner (HS) and controlled by an independent vascular
surgeon (PV) blinded to the treatment as far as possible.
Furthermore, the clinical classiﬁcation (CEAP C0eC6), the
Venous Clinical Severity Score without compression stock-
ings (VCSS-S), the Venous Segmental Disease Score (VSDS)
according to the DUS examination, the Venous Disability
Score (VDS),15 and HRQoL were assessed at entry and at the
1- and 2-year follow-ups.
Sample size
The basic assumption was that there is a clinically signiﬁcant
improvement in the intervention group if the VCSS-S
Table 1. Scoring-system for the treatment of superﬁcial venous insufﬁciency in the public health care system of Finland.
Reports of the Finnish Ministry of Social Affairs and Health 2010:33
UNIFORM CRITERIA FOR ACCESS TO NON-EMERGENT TREATMENT OF CHRONIC SUPERFICIAL VENOUS INSUFFICIENCY
ICD disease classiﬁcation
I87.2 Venous insufﬁciency (chronic)(peripheral)
I83.2 Varicose veins of lower extremities with both ulcer and inﬂammation
I83.9 Varicose veins of lower extremities without ulcer or inﬂammation
Primary health care/Information needed for non-emergency referral
 Severe venous insufﬁciency (C4e6) or lower extremity oedema due to venous insufﬁciency that does not
respond to treatment with compression stockings, or problems with varicose veins
 The referral must contain a clear description of the patient’s symptom, ﬁndings and degree of disability
(disability class).
Criteria for non-emergency surgical treatment within specialised health care (score 0e100)
The patient has reﬂux in a treatable vein that has been veriﬁed by clinical symptoms and ﬁndings and by exami-
nation with a Doppler or duplex device. Treatable vein means a vessel that exhibits reﬂux over a large area of the
lower extremity.
The indication for surgery is always based on evaluations case by case.
The threshold for treatment is a score of 50; treatment decisions that deviate from this must be explained in
writing. Surgery is not performed on patients whose score exceeds 50, if surgery is not expected to beneﬁt the
patient after due consideration of co-existing diseases and other factors.
 Degree of severity C4e6 [skin changes related to venous insufﬁciency, e.g., pigmentation or eczema (C4), skin
changes and cured leg ulcer (C5), skin changes and leg ulcer (C6)], bleeding varicosity or wide thrombophlebitis
50 points
 Degree of severity C 2e3: Varicosities (C2), oedema without skin changes (C3)
0 points Symptom-free
35 points: Has symptoms, but the patient’s ability to work or to function in daily life is not threatened
40 points: Has symptoms, working ability or ability to function in daily life can only be maintained with the use of a
medical compression stocking
50: points Has symptoms, working ability or ability to function in daily life cannot maintained even with the with the
use of a medical compression stocking
 Pain
0 points No pain
2 points Occasional, no need for analgesics
4 points Daily
6 points Continuous
 Varicose veins
0 points No varicosities
2 points One varicosity
4 points Several varicosities in the area either of the calf or of the thigh
6 points Vast areas of varicose veins in the area of the calf and of the thigh
 Swelling
0 points No swelling
2 points Ankle swelling in the evenings
4 points Swelling above the ankle also in the afternoons
6 points Swelling above the ankle from the morning
 Treatment with stocking
0 points Not used
2 points Occasionally used
4 points Used most of the time
6 points Used continuously or patient cannot use stockings
Reference for scoring:
None
Current care guidelines (lower extremity venous insufﬁciency)
www.kaypahoito.ﬁ
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Table 2. The causes for excluding patients from randomization.
Cause n
C4eC5 disease 152
Compression therapy insufﬁcienta 49
C1 diseaseb 43
Comorbidity 26
Not willing to participate 16
C6 disease 15
Age >70 years 14
BMI >35 11
Do not want operation 11
Thrombophlebitis in history 5
Linguistic problems, pregnancy, moving abroad 5
Peripheral arterial disease 0
Lymphoedema 0
Total 347
a Patients had used compression therapy before the examination.
b Includes two patients with C2-disease but no symptoms.
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follow-up. Thus, with a standard deviation (SD) of 3 points at
the baseline, the sample size needed was 40 in each group,
with SD of 4 the sample size needed was 65. Anticipating a
loss to follow-up level of around 10%, we planned to recruit
at least 75 patients for each treatment arm.
Data analysis
Data were analysed both on an intention-to-treat basis and
according to the actual treatment performed. Patients who
underwent foam sclerotherapy treatment during the
follow-up (n ¼ 4) were not included in the analysis on
actual treatment performed, but only patients who un-
derwent surgery were compared with those who did not
undergo any invasive intervention. Continuous variables
were reported as mean, standard deviation (SD), and range.
Baseline and follow-up variables were compared using the
paired samples t-test and repeated measures test. Statisti-
cal analyses were performed using the SPSS statistical
software for Windows (SPSS version 19.0, SPSS Inc., Chi-
cago, IL). A p value less than .05 was considered statistically
signiﬁcant.Table 3. Main source of reﬂux in patients in the two groups.
Surgery
No previous
surgery
R
s
GSV from groin 40
GSV from perforator 1
SSV 2
GSV þ SSV 1
AASSV and/or PASV from the groin 5
AASSV and/or PASV from perforator 1
Other thigh vein from groin 0
Other thigh vein from a perforator 1
Perforator at crural level 1
52 2
AASV ¼ Anterior accessory saphenous vein; GSV ¼ Great sapheno
saphenous vein.The study was approved by the ethics committee of
Helsinki University Central Hospital.RESULTS
A total of 77 patients were randomized to the compression
group and 76 patients to the surgery group. Baseline
characteristics of the patients are described in Table 4. Of
the patients in the surgery group, 70/76 (92.1%) were
operated on. The median delay between randomization and
the operation was 4.9 months in the surgery group (range
0.6e11.6 months). No major complications were
encountered.
Initially, 5/153 patients dropped out of the study soon
after the randomization (Fig. 1). At 2 years, 11/77 (14.3%)
patients in the compression group had been operated on,
and one patient (%) in the surgery group had refused sur-
gery and wanted to continue with compression therapy.
Two patients in each groups were treated elsewhere with
foam sclerotherapy during the 2-year period. Seventy-two
(93.5%) patients in the compression group and 73 (96.1%)
in the surgery group completed the 2-year QoL assessment.
Seventy (91.0%) and 68 (89.4%) patients in the groups,
respectively, underwent the 2-year clinical follow-up and DD
examination (Fig. 1).Intention-to-treat analysis
In the beginning of the study, all patients had a clinical
classiﬁcation of C2eC3. At the 2-year follow-up, 80.0%
(56/70) of the patients in the conservative arm were still
at C2eC3 as opposed to the 29.4% (20/68) in the surgery
group. Skin changes were present in 4.3% (3/70) of the
patients in the compression group and in 1.5% (1/68) in
the surgical arm, with a clinical classiﬁcation of C4
(Table 5).
The VCSS-S decreased 1.1 points in the compression
group for 2 years, and 4.2 in the surgical group (p < .001)
(Table 6). Corresponding VSDSs were 7.7 and 7.0 (n.s.) in
the compression group, and 8.2 to 0.9 in the surgery group
(p < .0001) (Table 6).Compression
ecurrence after
urgery
No previous
surgery
Recurrence after
surgery
9 40 8
1 1
6 9 6
0 1
4 6 4
2 0 0
1 0 0
1 0 0
0 1 1
4 58 19
us vein; PASV¼Posterior accessory saphenous vein; SSV¼Small
Table 4. Baseline characteristics of patients in randomized groups.
Variable Compression stockings Surgery
n ¼ 77 n ¼ 76
Mean (SD)
age (years)
46
(9.0; 29e66)
48
(10.1; 1e69)
Sex (M/F) 8/69 11/65
BMI (SD) 25.3
(3.3; 19.6e32.7)
25.1
(4.1; 18.6e34.7)
Previous
surgery % (n)a
24.7 (19) 31.5 (24)
Unilateral/
bilateral diseaseb
52/25 43/31
Clinical classiﬁcation
(C2/C3)
22/55 14/62
a Patient has had previous varicose surgery of the same leg that is
currently treated.
b In the case of bilateral disease, the leg with heavier symptoms
has been evaluated.
674 H. Sell et al.At baseline, 95% of the patients in both groups had a
venous disability score of I (i.e. patients were symptomatic
but able to carry out daily activities without compression
therapy). At the 2-year follow-up, the VDS was 0 for 10.0%
(7/70) of the patients in the compression group and for
70.6% (48/68) in the surgery group.
The health-related quality of life measured with a disease
speciﬁc Aberdeen questionnaire did not change signiﬁcantly
in the compression group. In the surgery group, it was
signiﬁcantly better at the 1- and 2-year follow-ups (Fig. 2).Per treatment analysis
At 2 years, 81 patients had been operated on, while 61
patients had been treated conservatively. Of these, com-
plete follow-up was available in 133 patients. At the 2-year
follow-up, 94.9% (56/59) of the patients in the conservative
treatment group were still at C2eC3 as opposed to the
27.0% (20/74) in the surgical arm. Furthermore, 5.1% (3/59)
of the patients in the compression group and none in theFigure 1. Flow chart of the studysurgery group had developed skin changes, that is the dis-
ease had progressed to the clinical classiﬁcation C4
(Table 4).
The VCSS-S was 4.6 at entry and 3.9 at completion of the
study in the compression group (p < .01) and decreased
from 4.8 to 0.5 in the surgery group (p < .001) (Table 5).
Corresponding VSDSs were 7.8 and 7.9 (n.s.) in the
compression group, but decreased from 8.2 to 0.9 in the
surgery group (p < .0001) (Table 6).
At baseline, 94.8% of the patients in both groups had a
VDS of I. At the 2-year follow-up, the score was 0 in 3.4% (2/
59) of the cases in the compression group and in 71.6% (53/
74) in the surgery group.
The health-related quality of life measured with a
disease-speciﬁc Aberdeen questionnaire (without informa-
tion on the compression treatment) did not change signif-
icantly in the compression group. In the surgery group, it
had improved signiﬁcantly at the 1- and 2-year follow-ups
(Fig. 2).
At the 2-year follow-up visit, 26 patients in the
compression group were scheduled for elective invasive
treatment of the superﬁcial venous reﬂux.DISCUSSION
Statement of principal ﬁndings
Varicose veins associated with superﬁcial venous reﬂux are
very common in the adult population. There is a grey area
of uncertainty between purely cosmetic and clinically sig-
niﬁcant disease. The ﬁrst-line treatment of superﬁcial
venous reﬂux is compression stockings, which should lower
the increased venous pressure and relieve symptoms. In the
current RCT, we evaluated the treatment of uncomplicated
superﬁcial venous reﬂux in patients who suffered from
varicose veins with or without leg swelling but no skin
changes. Patients were randomized to receive surgery or
conservative treatment with compression stockings and
followed up for 2 years after the randomization. Patientspatients. Qol ¼ quality of life.
Table 5. The change in CEAP clinical classiﬁcation during the ﬁrst
and second year in the study groups.
Intention to treat
Baseline 1 year 2 years
Compression Surgery Compression Surgery
C2 C0eC1 2 11 3 9
C2 12 0 8 1
C3 7 0 7 0
C4 0 1 1 1
C3 C0 5 31 6 35
C2 16 2 10 5
C3 29 24 31 14
C4 2 1 2 0
Per treatment
Baseline 1 year 2 years
Compression Surgery Compression Surgery
C2 C0eC1 0 13 0 12
C2 11 1 8 1
C3 7 0 7 0
C4 0 0 1 0
C3 C0 0 34 0 40
C2 17 1 11 4
C3 28 25 30 15
C4 2 1 2 0
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the measures of clinical severity of the disease, as well as in
disease-speciﬁc quality of life. In addition, after the study
follow-up ended, 26 patients in the compression therapy
group sought treatment for the superﬁcial venous reﬂux.
Possible mechanisms and implications for clinicians or
policymakers
The starting-point that compression stockings are an
adequate treatment method for class C2eC3 chronic venous
disease led the Finnish authorities to suggest that most of
these patients could be treated conservatively outside the
public surgical service.13 The applied scoring system wasTable 6. Venous clinical severity score (VCSS) and venous segmental dis
Intention to treat
n VCSS-S VSDS
Baseline
Compression 77 4.6 (1.1; 3e8) 7.7 (2.5; 2
Surgery 76 4.8 (1.1; 2e7) 8.2 (2.5; 2
1 year
Compression 73 3.6 (1.7; 0e8)a 7.2 (3.8; 0
Surgery 70 0.8 (1.0; 0e5)b 0.6 (1.7; 0
2 years
Compression 70 3.5 (2.0; 0e7)a 7.0 (3.7; 0
Surgery 69 0.6 (1.0; 0e5)b 0.9 (1.7; 0
VCSS-S: 0e3 points each: Pain, varicose veins, venous oedema, skin
duration, ulcer size (according to Rutherford et al. JVS 2000;31:13
anterior/posterior ascending saphenous vein, other veins in thigh, pe
perforators calf, other calf veins, other superﬁcial leg veins.
a p < .05 compression vs. surgery, independent sample t-test.
b p < .05 1 and 2 years compared with baseline, repeated measuresbased on opinions of an expert group rather than scientiﬁc
data. This recommendation is controversial as a clear prob-
lem in this scoring is that it is not systematically validated and
that it is partially based on subjective variables such as aching
and the need for pain killers. Moreover, the scoring is inter-
preted differently by different physicians and in different
hospitals. More objective information about the effective-
ness of surgery was needed, andwe therefore introduced the
present study soon after the implementation of the scoring
system in our hospital. The study was planned along the lines
of a Finnish study on another common surgical problem.17
The present results were not only reported in terms of the
VCSS and a disease-speciﬁc quality-of-life assessment in-
strument as suggested by the Clinical Practice Guidelines of
the Society for Vascular Surgery and the American Venous
Forum,18 but also in regard to the VSDS and VDS. The study
shows quite clearly that patients with duplex-veriﬁed truncal
reﬂux beneﬁt from surgery as evaluated with most of the
available, objective as well as subjective methods and that
the beneﬁt is still seen after 2 years.Strengths and weaknesses in relation to other studies
The results are in agreement with the only other RCT
comparing open ablative surgery and compression therapy
for varicose veins by Michaels et al., studying the practices
at public institutions in Exeter and Shefﬁeld.19 They
compared ﬂush ligation of reﬂux and GSV stripping with
conservative management of uncomplicated primary vari-
cose veins in 246 patients in an RCT.19 We treated 153
consecutive patients with axial reﬂux seen in everyday
practice. The operations were performed by vascular sur-
geons according to their own DUS ﬁndings by means of
ligation, stripping, and local phlebectomy. We encountered
no major complications and did not systematically record
minor ones. The clinical surveillance in the British study was
at 12 months, with a postal interview at 36 months, and the
assessors were not blinded. In the present study, clinical
surveillance was conducted at 1 and 2 years, and the results
were assessed by the researcher as well as an independentease score (VSDS) at baseline and at the 1-year and 2-year controls.
Per treatment
n VCSS-S VSDS
e14) 63 4.6 (1.1; 3e8) 7.8 (2.5; 2e13)
e14) 81 4.8 (1.1; 2e7) 8.2 (2.5; 2e14)
e14)a 62 3.9 (1.4; 0e8)a 8.0 (3.2; 0e14)
e10)b 75 0.9 (1.2; 0e5)b 0.6 (1.4; 0e9)
e14)a 59 3.9 (1.7; 0e7)a 7.9 (2.8; 0e14)
e7)b 74 0.5 (0.9; 0e5)b 0.9 (1.5; 0e7)
pigmentation, inﬂammation, induration, number of ulcers, ulcer
07e1312).VSDS: 0e3 points each: Great saphenous vein tight,
rforators thigh, great saphenous vein calf, small saphenous vein,
analysis.
Figure 2. Disease-speciﬁc quality of life (Aberdeen without
compression stockings) in patients with varicose veins treated with
compression therapy or open ablative surgery. A ¼ intention-to-
treat analysis. B ¼ per-treatment analysis (0 ¼ conservative
treatment; 1 ¼ surgery) (Point estimate and 95% CI).
Black ¼ Baseline; Green ¼ 1 year; Red ¼ 2 years.
676 H. Sell et al.assessor who was blinded to the treatment. Furthermore,
the quality-of-life instruments were different. We used a
disease-speciﬁc HRQoL instrument as opposed to the un-
speciﬁc SF-6D questionnaire employed in the British study.
In the British study, 35% of the patients were lost to follow-
up in the surgical group and 17% in the conservative group at
the 1-year clinical control. The corresponding ﬁgures in our
study were 8% and 5%. The crossover rate was well below
10% in both studiesdin our study, it was 3% at 1 year.
Randomization in our study was performed with sealed en-
velopes concealing allocation to the intervention groups.Endovenous surgery
After the study, the treatment of superﬁcial truncal reﬂux
has taken major steps towards less invasive procedures, that
is catheter-based ablation techniques and ultrasound-
guided foam sclerotherapy. With catheter-based occlusion
techniques, the same result can be achieved with lower
morbidity.20,21 However, our results are still relevant as
there is evidence showing that the long-term results of
surgery are as good as those of laser or radiofrequency
ablation of saphenous veins, provided that the surgery is
performed after careful ultrasound evaluation. The large
crossover percentage after the completion of the study also
shows that, even if the disease is considered mild at the
original evaluation, the patients as well as the treating
physicians disagree, to some extent, with a too restrictive
approach. One of the strengths of this study is that all pa-
tients were evaluated with ultrasound diagnostics by the
treating surgeon.22Strengths and weaknesses of the study
The weaknesses of our study are that we included all
types of signiﬁcant axial reﬂux and not only GSV insufﬁ-
ciency, as well as previously operated patients. This makes
the patients a rather inhomogeneous group but improves
applicability to routine healthcare circumstances. In
studies where the inclusion criteria are very strict and only
a minority of the patients are randomized, the generaliz-
ability to the particular patient group is better, but poorer
to wider patient indications. Another downside is that the
follow-up was too short to demonstrate the long-term
recurrences. Furthermore, we did not record the compli-
ance for compression therapy. The patients received the
compression stockings free of charge, but we do not know
how many patients really wore the stockings daily. A
strength of our study is that patients remained in the
study; only ﬁve patients quit, mostly because of moving to
another area. Also the crossover rate was small in our
study.Conclusion
Patients with varicose veins with C2eC3 clinical class
beneﬁt from surgical elimination of superﬁcial venous reﬂux
when compared with compression stockings only. All
measured parameters showed better results in the surgical
arm at 1 and 2 years of follow-up.
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